
Sildro 4mg Capsule 10s
Out of Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Sildro 4mg Capsule 10s
This medicine is effective in treating the symptoms of Benign Prostatic Hyperplasia (BPH) such as urinary frequency and difficulty in urinating
How Sildro 4mg Capsule 10s works
Sildosin relaxes the smooth muscles present in the prostate and bladder, it reduces the symptoms of BPH by improving urine flow.
How To Use Sildro 4mg Capsule 10s
- Take this medicine as directed
Special Precautions for Sildro 4mg Capsule 10s
- Consult your physician or pharmacist before taking silodosin if you have any allergies before taking the medication
Benefits Of Sildro 4mg Capsule 10s
- It helps to treat difficulty in urination and a strong urge to experience
Side Effects Of Sildro 4mg Capsule 10s
- Hypotension, Myocardial Ischemia, Muscle pain, Back pain, Flusing
What If I Missed A Dose Of Sildro 4mg Capsule 10s
Health And Lifestyle
Drug Interaction
- protease inhibitor (ritonavir)
Drug Food Interaction
- N/A
Disease Explanation

Age-related growth of the prostate gland known as benign prostatic hyperplasia (BPH) is common in men. Urinary symptoms include difficulties peeing, a weak urine stream, frequent urination, and trouble emptying the bladder entirely can be caused by this disorder. Although BPH is not fatal, it can have a substantial negative influence on quality of life and may need to be treated with medication or surgery to reduce symptoms.
Safety Advice for Sildro 4mg Capsule 10s
- High risk
- Moderate risk
- Safe
No particular safety measures are suggested.
No particular interactions were found.
Use under medical supervision during pregnancy.
There are no particular safety issues to be aware of.
No particular safety measures are indicated.
Written By
Ashwani Singh
Master in Pharmacy
Content Updated on
Friday, 5 July, 2024
